Technology driven biopharma player with differentiated portfolio and global presence

Ranked one of the fastest growing and 12th largest pharma player in India
(* as per AIOCD-AWACS March 2021)

Developing India’s first indigenous mRNA vaccine for

Committed to ensure dedicated support in the fight against

Committed to ensure dedicated support in the fight against COVID-19

Know More

Emcure Pharmaceuticals Limited was built with the purpose and core belief of making Effective Medicines to Cure patients enabling them to lead healthier lives

We are a fast-growing Indian pharmaceutical company engaged in developing, manufacturing, and marketing a broad range of biopharmaceutical products globally. Emcure’s differentiated product portfolio lends an unparalleled competitive advantage establishing its presence in all major therapies in the domestic market. With a presence in over 70 countries, Emcure’s goal is to constantly innovate and deliver affordable & high-quality healthcare solutions to people.

12th Largest Pharma Company in India
9,000+ Employees
70+ Countries with presence

Focus Areas

Established presence in key therapeutic areas

Vitamins, minerals and nutrients
Anti-Retro Virals
mRNA vaccine

Research and Development

Leveraging technology as the key differentiator in the mission to develop products that serve across diverse markets. Emcure’s in-house research and development capabilities span both chemistry and biologics providing a unique synergy to develop innovative solutions

Empowered by the strength of ~500 qualified scientists ably led by industry stalwarts: Dr Mukund Gurjar, Dr Sanjay Singh and Dr Deepak Gondaliya

Presence across 5 dedicated facilities focused towards API, formulation and biotechnology research

Read more


August 5, 2021

Emcure Pharma invested 400 cr at Sanand plant

August 5, 2021

India likely to get first mRNA vax by year-end

July 30, 2021

Gennova to use mRNA tech to develop Vax for Zika,TB

July 29, 2021

Emcure Pharma strengthens its board, adds 4 Independent Directors

July 27, 2021

Gennova likely to become second vaccine maker to receive advance from Centre

July 15, 2021

EXPLAINED: Why India-Made Gennova Vax Could Give Protection At A Fraction Of Cost Of Other mRNA Shots

Placeholder Image

Life at Emcure

At Emcure, we believe that the success and growth of the company is in the hands of our people. Hence, we are committed towards nurturing talent and providing equal opportunities for their further development.

Join us
Placeholder Image

Uncondition Yourself

Women’s Health continues to be a topic discussed in hushed tones with irrational stigmas and taboos associated with it. This platform aims to share real-life experiences, break myths & taboos and highlight facts, to change the dismal statistics around women’s health.